Join
Live feed
·
PRReleasevia Quantisnow
Insmed Incorporated logo

Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026

ByQuantisnow·Wall Street's wire, on your screen.
INSM· Insmed Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INSM (Insmed Incorporated) and more on Quantisnow.